Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2001 1
2002 1
2019 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Congenital plasminogen activator inhibitor type 1 deficiency"
Page 1
Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis.
Urano T, Suzuki Y, Iwaki T, Sano H, Honkura N, Castellino FJ. Urano T, et al. Curr Drug Targets. 2019;20(16):1695-1701. doi: 10.2174/1389450120666190715102510. Curr Drug Targets. 2019. PMID: 31309890 Free PMC article. Review.
Three distinct inhibitors of the fibrinolytic system that differently regulate these two steps are plasminogen activator inhibitor type-1 (PAI-1), alpha2-antiplasmin, and thrombin activatable fibrinolysis inhibitor (TAFI). ...A …
Three distinct inhibitors of the fibrinolytic system that differently regulate these two steps are plasminogen activator in …
Diagnosis of Immunoglobulin G4-related disease in a child with ligneous conjunctivitis: a novel mutation in plasminogen gene and plasminogen activator inhibitor-1 polymorphism.
Emiroğlu M, Bozkurt B, Emiroğlu HH, Koplay M, Koçak N, Karabağli P. Emiroğlu M, et al. Blood Coagul Fibrinolysis. 2023 Oct 1;34(7):456-461. doi: 10.1097/MBC.0000000000001246. Epub 2023 Jul 27. Blood Coagul Fibrinolysis. 2023. PMID: 37577870
It is an ultrarare autosomal recessive disease associated with congenital plasminogen (PLG) deficiency due to mutations in the PLG gene (6q26). ...She also had plasminogen activator inhibitor - 1 (PAI-1) NG_013213.1(N …
It is an ultrarare autosomal recessive disease associated with congenital plasminogen (PLG) deficiency due to mutations …
Hypofibrinolysis in patients with hypercoagulability: the roles of urokinase and of plasminogen activator inhibitor.
Lau HK, Teitel JM, Cheung T, Kung SK, Garvey MB. Lau HK, et al. Am J Hematol. 1993 Dec;44(4):260-5. doi: 10.1002/ajh.2830440408. Am J Hematol. 1993. PMID: 8237997
The prevalence of abnormalities of fibrinolysis in patients with venous thromboembolism is as yet unknown. Defined abnormalities include congenital dysfunction and deficiency of plasminogen, and probably impaired plasminogen activation secondary to ele …
The prevalence of abnormalities of fibrinolysis in patients with venous thromboembolism is as yet unknown. Defined abnormalities include …
Interaction of fibrinolysis and prothrombotic risk factors in neonates, infants and children with and without thromboembolism and underlying cardiac disease. a prospective study.
Nowak-Göttl U, Kotthoff S, Hagemeyer E, Junker R, Kehl HG, Vielhaber H, Kececioglu D. Nowak-Göttl U, et al. Thromb Res. 2001 Jul 15;103(2):93-101. doi: 10.1016/s0049-3848(01)00281-x. Thromb Res. 2001. PMID: 11457466
To evaluate the role of plasminogen activator inhibitor-1 (PAI-1) and tissue-type plasminogen activator (t-PA) in children with an estimated risk of vascular occlusion reported to range from 7% to 16%, we conducted a prospec …
To evaluate the role of plasminogen activator inhibitor-1 (PAI-1) and tissue-type plasminogen …
Paradoxical hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia.
Grünewald M, Siegemund A, Grünewald A, Konegan A, Koksch M, Griesshammer M. Grünewald M, et al. Haemophilia. 2002 Nov;8(6):768-75. doi: 10.1046/j.1365-2516.2002.00686.x. Haemophilia. 2002. PMID: 12410645
The results of activated partial thromboplastin time, endogenous thrombin potential, pro- and anticoagulant factor analysis did not differ between the two groups. Median tissue-type plasminogen activator concentration (TPA) was elevated significantly in haemo …
The results of activated partial thromboplastin time, endogenous thrombin potential, pro- and anticoagulant factor analysis did not differ b …